Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
| ▸ | TAS2R46 | P59540 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2575638 | 1.00 | LMNA (0.35) | LMNACYP3A4ALOX15TAS2R46MEN1 | |
| SCHEMBL28556508 | 0.88 | TAS2R46 (0.33) | LMNACYP3A4ALOX15TAS2R46MEN1 | |
| SCHEMBL585277 | 0.82 | TAS2R46 (0.38) | LMNACYP3A4ALOX15TAS2R46MEN1 | |
| SCHEMBL3504653 | 0.82 | TAS2R46 (0.38) | LMNACYP3A4ALOX15TAS2R46MEN1 | |
| SCHEMBL1153227 | 0.82 | TAS2R46 (0.38) | LMNACYP3A4ALOX15TAS2R46MEN1 | |
| SCHEMBL17627758 | 0.82 | TAS2R46 (0.38) | LMNACYP3A4ALOX15TAS2R46MEN1 | |
| SCHEMBL585278 | 0.82 | TAS2R46 (0.38) | LMNACYP3A4ALOX15TAS2R46MEN1 | |
| SCHEMBL8973506 | 0.80 | TAS2R46 (0.35) | LMNATAS2R46MEN1KMT2ARECQL | |
| SCHEMBL22442455 | 0.75 | MEN1 (0.44) | LMNATAS2R46MEN1KMT2ARECQL | |
| SCHEMBL22442456 | 0.75 | MEN1 (0.44) | LMNATAS2R46MEN1KMT2ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1072673-A2 | Perfume compositions | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-31 | — | — | EP | claimed |
| WO-2001005919-A2 | PERFUME COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-25 | — | — | WO | claimed |
| EP-3096839-B1 | SCENTED BODY COMPOSITIONS | MAORI S C LTD (IL) | 2021-08-11 | — | — | EP | disclosed |
| US-9943469-B2 | Scented body compositions | MAORI S.C. LTD. (IL) | 2018-04-17 | — | — | US | disclosed |
| EP-2734178-B1 | PERFUME | COTY INC (US) | 2018-01-17 | — | — | EP | disclosed |
| EP-2758027-B1 | PERFUME | COTY INC (US) | 2017-10-25 | — | — | EP | disclosed |
| US-20160338915-A1 | SCENTED BODY COMPOSITIONS | AMKIRI LTD (IL) | 2016-11-24 | — | — | US | disclosed |
| US-9109187-B2 | Oud odorants | FIRMENICH SA (CH) | 2015-08-18 | — | — | US | disclosed |
| US-9102898-B2 | Perfume | COTY INC. (US) | 2015-08-11 | — | — | US | disclosed |
| EP-2751238-B1 | OUD ODORANTS | FIRMENICH & CIE (CH) | 2015-06-17 | — | — | EP | disclosed |
| US-20140371121-A1 | OUD ODORANTS | FIRMENICH SA (CH) | 2014-12-18 | — | — | US | disclosed |
| US-20140128311-A1 | PERFUME | COTY INC. (US) | 2014-05-08 | — | — | US | disclosed |
| US-20130023592-A1 | PERFUME | COTY INC. (US) | 2013-01-24 | — | — | US | disclosed |
| EP-2181690-B1 | Perfume composition with reduced alcohol content | COTY INC (US) | 2011-11-09 | — | — | EP | disclosed |
| US-7737107-B2 | Trimethylcyclododecatriene derivatives, use thereof and perfumed products containing the same | Fils, V. Mane (FR) | 2010-06-15 | — | — | US | disclosed |
| EP-2181690-A1 | Perfume composition with reduced alcohol content | Coty Inc. (US) | 2010-05-05 | — | — | EP | disclosed |
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | V. MANE FILS (FR) | 2008-06-12 | — | — | US | disclosed |
| EP-1707185-A1 | Solvent materials and methods for preparing fragrance compositions | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2006-10-04 | — | — | EP | disclosed |
| EP-1072673-A2 | Perfume compositions | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-31 | — | — | EP | disclosed |
| WO-2001005919-A2 | PERFUME COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023592-A1 | PERFUME | PLK3, PLK4, SMURF1 | LMNA 2644/4885CYP3A4 1348/4885ALOX15 277/4885 |
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | CBR3, C5, OXER1 | LMNA 3511/4885CYP3A4 182/4885ALOX15 477/4885 |
| US-20140371121-A1 | OUD ODORANTS | OPRD1, OR10J3, DRD4 | LMNA 3939/4885CYP3A4 194/4885ALOX15 257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.